Consumer Health Diabetes
A cutting-edge tele-monitoring system, OPTIMUM (Optimising care of Patients via Telemedicine In Monitoring and Augmenting their control of Diabetes Mellitu...
November 12, 2024 | News
Diabetes Singapore and GSK aim to enhance awareness and improve lives affected by diabetes through educational talks and activities on World Di...
November 12, 2024 | News
Adults taking Mounjaro in a clinical trial lost on average 48 lb. at the highest dose1,2 Mounjaro delivered superior A1C reductions versus all comparato...
October 28, 2024 | News
Achieving a Significant Clinical Milestone in Assessing the ReCET™ System as a Groundbreaking Treatment for Type 2 Diabetes Endogenex, Inc., a clini...
October 16, 2024 | News
HighTide Therapeutics, Inc. (2511.HK), a clinical-stage biopharmaceutical company dedicated to developing multifunctional therapies for chronic liver and m...
September 12, 2024 | News
Yunovia, a drug R&D subsidiary of Ildong Pharmaceutical Group, announced on the 26th that the Ministry of Food and Drug Safety (MFDS) of Korea has clea...
August 28, 2024 | News
U.S. Food and Drug Administration expanded the indications of the Insulet SmartAdjust technology, an interoperable automated glycemic controller previously...
August 27, 2024 | News
AiViva Biopharma Inc., a clinical-stage biotechnology company, announced that it has fully enrolled and completed dosing the last patient in a Phase 1 tria...
August 26, 2024 | News
Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. (hereinafter referred to as "Sanyou Bio") and Guangdong JiAnTeBo Biotechnology Co., Ltd. (hereinafter r...
August 08, 2024 | News
Medical Technology and Devices (MTD) is pleased to announce the successful closing of the acquisition of Ypsomed's Pen Needles and Blood Glucose Monitoring...
August 05, 2024 | News
Eluminex Biosciences announced that their tri-specific fusion antibody drug, EB-105, has administered its first dose to a diabetic macular edema patient in...
July 29, 2024 | News
CordenPharma has announced its largest strategic investment to date with a committed spend of ~€900m over the next 3 years to grow its Peptide technol...
July 17, 2024 | News
Calliditas Therapeutics AB announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in&...
July 05, 2024 | News
Endogenex, a clinical-stage medical device company dedicated to improving outcomes in individuals with type 2 diabetes, announced it has closed an oversubs...
June 26, 2024 | News
Most Read
Bio Jobs
News